The National Institute of Biomedical Innovation, Health and Nutrition (NIBIOHN) was farmed in April 2015 by combining the National Institute of Biomedical Innovation (NIBIO) and the National Institute of Health and Nutrition (NIHN). NIBIOHN was founded with the goal of contributing to the development of innovative drugs and other products in Japan through research focused on fundamental technologies for drug and medical device discovery, as well as facilitating surveys and studies regarding the maintenance and promotion of health of Japanese people, specifically their nutrition and diet. Thus, NIBIOHN consists of NIBIO and NIHN. NIBIO specializes in drugs and other related fields, whereas NIHN specializes in food and nutrition. Each institute conducts research that takes advantage of its expertise. In addition. NIBIOHN will explore new research fields that could not exist without integrating the expertise of these two institutes. Although NIBIO is a relatively new research institute, it has made numerous contributions to the discovery of drugs and other products through industry-university-government cooperation. For instance, it received the Award for Contribution to Industry, Academia, and Government Cooperation In three consecutive years: for the development of new safety biomarkers using large-scale toxicogenomics database, for the world's first artificial hydroponic culture of a medicinal plant (glycyrrhiza), and for the world's first commercialization of liver cells obtained by differentiation of human iPS cells.
The following is the list of proceedings by scholars from National Institutes of Biomedical Innovation, Health and Nutrition that are published in OMICS International journals and conferences.